...that incorporate in-house or in-licensed delivery technology. Last year, BAX signed a deal to use RTP Pharma's...

...LSE:SKP;SKYE) fell 0.5p to 55.5p on news that it had acquired the remaining 59.8% of RTP Pharma...

...RTP's Insoluble Drug Delivery (IDD) nanoparticle technology is designed to improve the solubility of drugs. RTP Pharma Inc....

...SkyePharma (LSE:SKP; SKYE) acquired the remaining 59.8% of RTP Pharma (Toronto, Ontario) it did not already own...

...BAX will use insoluble drug delivery (IDD) technology from RTP Pharma to formulate injectable medications, including water-insoluble...
...exclusive manufacturing rights to resulting compounds, and RTP will receive license fees, milestones and royalties. RTP Pharma Inc....

...BAX will use insoluble drug delivery (IDD) technology from RTP Pharma (Montreal, Quebec) to formulate injectable medications...

...84.5p after announcing that it will buy a 40.2% stake in Canadian nanoparticle technology company RTP Pharma...

...Drug delivery play SkyePharma (LSE:SKP;SKYE) acquired a 40.2% stake in nanoparticle technology company RTP Pharma (Toronto, Ontario...

...methods of using supercritical fluid technology to create surface-modified, sub-micron sized particles of water-insoluble drugs. RTP Pharma Inc....